NASA powers down two instruments on twin Voyager spacecraft to save power
NEW YORK — NASA is switching off two science instruments on its long-running twin Voyager spacecraft to save power. The space ...
IFLScience1h
"Every Day Could Be Our Last": NASA Shuts Down Instruments On Aging Voyager Spacecraft
Unfortunately, the time has now come to turn off more instruments on both spacecraft. NASA announced yesterday it has shut down the cosmic ray subsystem experiment on Voyager 1, and will shut down ...
Space.com2h
NASA switches off Voyager instruments to extend life of the two interstellar spacecraft 'Every day could be our last.'
"The Voyagers have been deep space rock stars since launch, and we want to keep it that way as long as possible!" ...
NASA Shuts Off Voyager Science Instrument, More Power Cuts Ahead to Keep Both Probes Going
The twin probes should operate for about a year before the team is forced to shut off yet more instruments. The Voyager ...
Aviation Week Network2h
More Voyager Instruments Go Dark To Extend Life
NASA is turning off more science instruments on its Voyager 1 and Voyager 2 probes that could help extend the life of the ...
NASA makes crucial move to keep its legendary Voyager craft alive
Voyager 1 — launched in 1977 and now over 15.6 billion miles from Earth — started out with 10 science instruments, but now ...
New Atlas6h
NASA tweaks Voyager probes to help them hit a half century of service
A pair of extraordinary space missions that have been headed out of the solar system for almost half a century are getting a ...
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $15.72 Average Price Target from Analysts
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ...
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today ...
Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on ...
Voyager reports promising data for early stage trial in Alzheimer’s disease treatment
Voyager Therapeutics (VYGR) said on Monday that the company provided positive topline data from its early stage trial of VY7523, an antibody to selectively inhibit the spread of pathological tau in ...